EN
HI

Arvee Laboratories (India) Share price

ARVEE

164.01

1.56 (0.96%)
Last updated on 6 Oct, 2025 | 15:30 IST
BUYSELL
Today's High

169.99

Today's Low

158.10

52 Week Low

126.54

52 Week High

235.79

The current prices are delayed, login to your account for live prices

Arvee Laboratories (India) Share Key Metrics

Volume
355.00
Market Cap
180.74 CR
LTQ@LTP
3@164.01
ATP
163.14
Var Margin
26.3 %
Circuit Range
154.32-170.57
Delivery %
52.83 %
Value
57914.70
ASM/GSM
No
Market Lot
1

Arvee Laboratories (India) Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

39.66

Sector P/B

3.84

Sec. Div. Yield

0.42

Arvee Laboratories (India) Resistance and Support

Pivot 166.29

Resistance

First Resistance

170.58

Second Resistance

178.29

Third Resistance

182.58

Support

First Support

158.58

Second Support

154.29

Third Support

146.58

Arvee Laboratories (India) Futures & Options

Data Not Found

Arvee Laboratories (India) Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

73.5%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

26.5%

Others

0%

Total Promoters
MAR '25
73.5%
JUN '25
73.5%

Arvee Laboratories (India) Corporate Actions

DateAgenda
2025-08-12Quarterly Results
2025-05-09Audited Results & Others
2025-02-12Quarterly Results

Arvee Laboratories (India) News

No Data Found

About Arvee Laboratories (India) AboutThe

NSE : 2814  
BSE : 205428  
ISIN : INE006Z01016  

The Company was incorporated as Arvee Laboratories (India) Private Limited under the provisions of the Companies Act 1956 vide certificate of incorporation dated January 27 2012 in Ahmedabad Gujarat. Subsequently the name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public company vide shareholder’s approval dated September 11 2017 and vide fresh certificate of incorporation dated September 19 2017.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY2012- The Company was incorporated as Arvee Laboratories (India) Private Limited.2013- Acquired land building and machineries from Skylink Chemicals Private Limited and started manufacturing unit.- Started construction of its first plant for Thiophene Derivatives.- Completes construction and commissioning of its Thiophene Derivatives Plant.2014- Plant inspected and approved by leading India pharmaceutical manufacturer for supply of Thiophene Derivatives.- Started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid.- Received ISO 9001:2008 accreditation for NABCB and DAKKS from TUV NORD.- Plant inspected and approved by an American X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.- Plant inspected and approved by a European X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.2015- Completed construction and commissioning of plant for Nitro Derivatives of Isophthalic Acid.- After receiving inspection approval our Company gets order for yearly supply of Nitro Derivatives of Isophthalic Acid to leading contrast media manufacturer in the United States of America.- Export to United States of America (USA) started.- Plant inspected and approved by European manufacturer for supply of Thiophene Derivatives.- Export of Thiophene Derivatives started to Europe.2016- Receives internal approvals for our Nitro Derivatives of Isophthalic acid from leading XRay contrast media manufacturer in Europe.- Receive approval for our Sulfo Derivatives of Isophthalic acid from a large polymer manufacturer in the United States of America and received yearly order for supply of Sulfo Derivatives to the USA.- Crossed turnover of Rs. 25 crores.2017- Plant inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the manufacturer.- Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world.- The name of our Company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public limited company.

Read More

Arvee Laboratories (India) Management

NamePosition
Mr. Shalin Sudhakarbhai Patel Managing Director
Mr. Shalin Bharat Chokshi Whole Time Director
View More

Arvee Laboratories (India) FAQs

Arvee Laboratories (India) शेयर का खरीद मूल्य 164.01 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Arvee Laboratories (India) शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Arvee Laboratories (India) शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Arvee Laboratories (India) शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Arvee Laboratories (India) शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.84 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Arvee Laboratories (India) का मार्केट कैप 180.74 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Arvee Laboratories (India) शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 235.79 और 126.54 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।